anonymous
Guest
anonymous
Guest
What divisions have confirmed upcoming layoffs?
Good question....anti-Infectives???
What divisions have confirmed upcoming layoffs?
What divisions have confirmed upcoming layoffs?
Non-sales but sick of the f-ing layoff rounds. I've had enough. Trying to stay in Irvine for personal reasons but good god management is asking us to jump ship from the constant layoffs. I'm so glad someone wrote an anonymous comment to Nicholson during the R&D town hall stating AGN feels like a sinking ship.
this is absolutely BS’s fault. He made a bonehead decision and got the restasis patent invalidated. The product had 6years left on it. He is losing $6 billion because of what he did. Guess who will pay for it?
This better be his resignation phone call. Why would there be any restructuring the day 1/3 of all sales reps are flying to a vraylar meeting anyways?
Well they fired 1/2 the Women’s Health Reps literally right after Liletta launched
Not sure why people give Saunders a free pass and don’t point fingers at him for losing almost $50 billion in market cap. Patent expiration’s happen all the time in Pharma and it’s the job of the CEO and management to “manage” patent issues. The single telling factor to me is how Saunders appears to have destroyed the credibility of Allergan with investors as well as the rest of the Pharma community. What was once a very respected company (Allergan Legacy) is now a joke. As many have pointed out, had a regular employee screw up as bad as Saunders has, they would have been fired. I see 2018 being a lot like 2017. Poor M&A phase 3 data which squashes any stock price movement. Slight losses in sales of old drugs and potential past high earning drugs. Once earnings go down and poor data comes out, its game over for AGN. This stock will be sub $100’s and a sale for dirt will occur. Currently I would be shocked if someone offered to buy AGN. No free cash flow with diverging nonGAAP and GAAP numbers is not good. YoverY growth and earnings could be a smoke screen. Been long for almost 30 years and have never seen AGN so mismanaged and run by executives who only know how to buy and sell. Bring back Pyott and get rid of this incompetent punk Saunders.
Allergan will continue to downsize. Too bloated for current environment. Will lose 20% plus in January. Specialty reps are just glorified pc reps. Too much overlap with access decreasing yearly. Also if don't reduce managers, then more reps will leave. Too much micromanagement and too little company surviving management. Lots of talk about growth pharma but just talk and market cap drops almost daily. Used to be a good place to work.
Watch the stock run the opening bell of the new year.
Take it to the bank.
Watch the stock run the opening bell of the new year.
Take it to the bank.
Please give detailed reasons why. I won’t hold my breath
Because we're going to have a great fourth quarter. Just watch and wait for the report.
Not a troll at all. And I'm only invested in one pharma stock right now. And yes, I care about our performance and employees and colleagues and not just the stock price.
All the fun is in volatility and contrarianism. There's got to be a bottom somewhere. I say this is it.
You say otherwise? Bet your hand on a big short. Sport.
An early retirement initiative will be offered to employees with 15+ years of service. If we refuse to accept the offer, then we will lose the opportunity to accept it later if we lose our job when the wave of cuts go in to effect. Good luck!